Feldman Legal Advisors

We are excited to see our Managing Partner, David Feldman, share his insights on navigating the ever-changing landscape of New York’s cannabis market at #BOFCNY25 November 6, 2025. As regulators, equity advocates, and industry leaders come together to discuss how to stay ahead of shifting rules and enforcement trends, David’s perspective on building agile, compliant business models will be invaluable. #CannabisLeaders #Regulation #Policy #FeldmanLegalAdvisors

Feldman Legal Advisors PLLC is proud to sponsor Business of Cannabis: New York! 🌿⚖️ As trusted advisors in the cannabis, psychedelics, and corporate transactional sectors, we’re excited to support an event that brings together leaders shaping the future of the industry. 🔗 Learn more about the event: Business of Cannabis: New York

FLA Partner, David Feldman, was recently quoted in Lexology PRO on the SEC’s consideration of moving U.S. public companies from quarterly to semiannual reporting: “The argument for moving to six-month reporting is to seek to address one of the larger criticisms of becoming a public company, namely, that there is tremendous pressure every quarter to meet or beat short-term Wall Street expectations. Proponents of less reporting say that this reduces the focus on long-term planning and willingness to undertake capital expenditures where the benefits are down the road.” This potential shift raises important questions about balancing transparency, regulatory burden, and long-term growth. Lexology subscribers can view the entire article, linked below. https://lnkd.in/dV8nPCTD

Join FLA Partner, David Feldman, in New York City on Thursday, September 12, 2025, for an exclusive live simulcast connecting New York City and Bordeaux, France as part of Science in the City International. David will be speaking on a Legal and Finance Panel from 10:00 am - 10:40 am EST. The panel will provide an overview of the US legal cannabis landscape, prospects for legalization and cross-border opportunities. This high-level broadcast brings together global leaders in law, medicine, wellness, and finance, fostering dialogue at the intersection of science, policy, and opportunity. 📍 605 Third Avenue, Suite 2300, New York, NY 10158 📅 Thursday, September 12, 2025 ⏰ Time: 9:00 a.m. (Registration) https://lnkd.in/eeEUaGqM We hope to see you there!

We are proud to share that our partners, Courtney Barnes and David Feldman, have been recognized in the Global Top 200 Cannabis Lawyers 2025–2026 Directory, published today by Cannabis Law Report and Cannabis Law Journal.   This recognition highlights their leadership and dedication to guiding clients through complex regulatory, corporate, and compliance issues in cannabis and emerging industries.   #CannabisLaw #Top200 #FeldmanLegalAdvisors #GlobalRecognition https://lnkd.in/eJg3GrN

We are thrilled to welcome Dr Jessica Steinberg as our newest Associate at Feldman Legal Advisors PLLC. Based in the UK and licensed to practice law in England & Wales, Jessica brings a truly global perspective to our practice. Jessica earned the first PhD on regulated cannabis from the University of Oxford, where her groundbreaking research spanned 11 countries and focused on global legal reform and market development. She has advised public and private entities, investors, and government bodies across emerging therapies and technologies, and her work has been recognized on the international stage. At FLA, Jessica will support our clients with compliance, regulatory strategy, and transactional matters, expanding the firm’s international footprint in highly regulated and rapidly evolving industries. Please join us in giving Jessica a warm welcome to the family!

We are honored and humbled to share that Chambers and Partners has recognized our firm and both of our partners in its prestigious 2025 rankings: 🏆 Our law firm has been ranked Band 1 in Psychedelics Law 🏆 Courtney Barnes has been named a Band 1 Psychedelics Attorney 🏆David Feldman has been ranked as a Band 3 Cannabis Attorney Chambers is globally respected for its rigorous, independent research process and peer-reviewed rankings, making these distinctions all the more meaningful. These acknowledgments reflect our commitment to the emerging psychedelics and cannabis movements, and to the communities, patients, companies, and visionaries driving them forward. We are so grateful that our work is more than legal—it’s mission-driven advocacy grounded in integrity and hope for meaningful change. We thank our clients, colleagues, and peers for your trust and continued collaboration. 

Feldman Legal Advisors is pleased to share a recent article by our founder, David Feldman, published in Law360: "Why Teaching Business Law Has Made Me a Better Corporate Lawyer." We’re grateful to his students and colleagues who continue to inspire and inform this important work. #CorporateLaw #LegalEducation #Law360 #FeldmanLegalAdvisors

New Mexico just made history. Governor Michelle Lujan Grisham has signed SB 219—the Medical Psilocybin Act—into law, making New Mexico the third U.S. state to legalize psilocybin access for therapeutic use, and the first state to enact an access model through the state legislature. The law creates a state-regulated framework for psilocybin-assisted therapy to be used in treating specified qualifying conditions such as PTSD, depression, and substance use disorders, with a projected implementation date of December 31, 2027. We are happy to celebrate a major milestone for psychedelic policy—and for mental health innovation across the U.S.

Colorado has taken a historic step in implementing its Natural Medicine Program with the licensure of its first psilocybin healing center. This milestone reflects meaningful progress toward the establishment of an accessible and regulated framework for psychedelic-assisted therapy. Please note that regulated psilocybin services are not yet available to the public. Additional components of the supply chain — including licensed cultivators, manufacturers, and testing laboratories — must first also be approved under the state’s regulatory scheme. If you are interested in learning more about Colorado’s Natural Medicine Program, send us a message.